The United States Food and Drug Administration (FDA) has issued a cybersecurity alert concerning software in the Illumina NextSeq 550Dx, MiSeqDx, NextSeq 500, NextSeq 550, MiSeq, iSeq, and MiniSeq next generation sequencing instruments. FDA notes that the cybersecurity vulnerability affects the Local Run Manager (LRM) software and can lead to someone taking control of the affected instrument remotely. To read the FDA cybersecurity alert concerning the Illumina software, use the link below.
https://www.fda.gov/medical-devices/letters-health-care-providers/illumina-cybersecurity-vulnerability-may-present-risks-patient-results-and-customer-networks-letter?utm_medium=email&utm_source=govdelivery